A phase I/II study of preoperative TS-1 combined chemoradiation therapy for patients with large type 3 or type 4 gastric cancer (OGSG 1303) - A phase I/II study of preoperative TS-1 combined chemoradiation therapy for patients with large type 3 or type 4 gastric cancer (OGSG 1303)

Osaka Gastrointestinal cancer chemotherapy Study Group (OGSG)0 个研究点目标入组 10 人开始时间: 2014年4月28日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) with active double cancers excluding carcinoma in situ and/or prior cancer cured with longer than 5 year interval period 2) with a history of severe allergy against medicine 3) with infectious disease and febrile condition (over 38 centigrade) 4) pregnant or nursing female 5) male expecting pregnancy of partner 6) with a history of cardiac infarction within 6 months 7) under continuous steroids medication 8) Patients who are received systemic continuous administration of flucytosine, phenytoin or warfarin 9) bleeding from gastrointestinal tract 10) with uncontrollable diarrhea (watery stool and/or frequent diarrhea) 11) with HBs antigen+, and/or HCV-antibody+ 12) with severe diseases: autoimmune diseases, intestinal paralysis, interstitial pneumonitis/pulmonary fibrosis, ischemic cardiac diseases 13) Any other patients whom the physician in charge of the study judges to be unsuitable

发起方

Osaka Gastrointestinal cancer chemotherapy Study Group (OGSG)